Radient Technologies Inc (RDDTF)
0.00
USD |
OTCM |
May 21, 16:00
Radient Technologies Total Assets (Quarterly): 20.63M for Dec. 31, 2022
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 20.63M |
| September 30, 2022 | 20.54M |
| June 30, 2022 | 21.76M |
| March 31, 2022 | 22.22M |
| December 31, 2021 | 22.64M |
| September 30, 2021 | 22.44M |
| June 30, 2021 | 22.88M |
| March 31, 2021 | 23.21M |
| December 31, 2020 | 39.76M |
| September 30, 2020 | 42.88M |
| June 30, 2020 | 43.45M |
| March 31, 2020 | 40.85M |
| December 31, 2019 | 58.21M |
| September 30, 2019 | 57.41M |
| June 30, 2019 | 61.70M |
| March 31, 2019 | 45.71M |
| December 31, 2018 | 47.55M |
| September 30, 2018 | 51.88M |
| June 30, 2018 | 28.33M |
| March 31, 2018 | 23.24M |
| December 31, 2017 | 24.52M |
| September 30, 2017 | 11.78M |
| Date | Value |
|---|---|
| June 30, 2017 | 12.79M |
| March 31, 2017 | 11.33M |
| December 31, 2016 | 5.991M |
| September 30, 2016 | 3.793M |
| June 30, 2016 | 3.834M |
| March 31, 2016 | 4.032M |
| December 31, 2015 | 3.340M |
| September 30, 2015 | 3.613M |
| June 30, 2015 | 4.112M |
| March 31, 2015 | 4.298M |
| December 31, 2014 | 9.669M |
| September 30, 2014 | 11.15M |
| June 30, 2014 | 13.98M |
| December 31, 2013 | 0.374M |
| September 30, 2013 | 0.4057M |
| June 30, 2013 | 0.4081M |
| March 31, 2013 | 0.4363M |
| December 31, 2012 | 0.4781M |
| September 30, 2012 | 0.4903M |
| June 30, 2012 | 0.475M |
| March 31, 2012 | 0.5205M |
| September 30, 2011 | 0.124M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
20.54M
Minimum
Sep 2022
61.70M
Maximum
Jun 2019
34.71M
Average
23.21M
Median
Mar 2021
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
| Lexaria Bioscience Corp | 6.352M |
| Liminal Biosciences Inc (DELISTED) | 23.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 31.69M |
| Shareholders Equity (Quarterly) | -11.06M |